Cargando…

Integrated use of laboratory services for multiple infectious diseases in the WHO European Region during the COVID-19 pandemic and beyond

Technical advances in diagnostic techniques have permitted the possibility of multi-disease-based approaches for diagnosis and treatment monitoring of several infectious diseases, including tuberculosis (TB), human immunodeficiency virus (HIV), viral hepatitis and sexually transmitted infections (ST...

Descripción completa

Detalles Bibliográficos
Autores principales: Simões, Daniel, Ehsani, Soudeh, Stanojevic, Maja, Shubladze, Natalia, Kalmambetova, Gulmira, Paredes, Roger, Cirillo, Daniela Maria, Avellon, Ana, Felker, Irina, Maurer, Florian P, Yedilbayev, Askar, Drobniewski, Francis, Vojnov, Lara, Johansen, Anne S, Seguy, Nicole, Dara, Masoud
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Centre for Disease Prevention and Control (ECDC) 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9306259/
https://www.ncbi.nlm.nih.gov/pubmed/35866437
http://dx.doi.org/10.2807/1560-7917.ES.2022.27.29.2100930
_version_ 1784752507254210560
author Simões, Daniel
Ehsani, Soudeh
Stanojevic, Maja
Shubladze, Natalia
Kalmambetova, Gulmira
Paredes, Roger
Cirillo, Daniela Maria
Avellon, Ana
Felker, Irina
Maurer, Florian P
Yedilbayev, Askar
Drobniewski, Francis
Vojnov, Lara
Johansen, Anne S
Seguy, Nicole
Dara, Masoud
author_facet Simões, Daniel
Ehsani, Soudeh
Stanojevic, Maja
Shubladze, Natalia
Kalmambetova, Gulmira
Paredes, Roger
Cirillo, Daniela Maria
Avellon, Ana
Felker, Irina
Maurer, Florian P
Yedilbayev, Askar
Drobniewski, Francis
Vojnov, Lara
Johansen, Anne S
Seguy, Nicole
Dara, Masoud
author_sort Simões, Daniel
collection PubMed
description Technical advances in diagnostic techniques have permitted the possibility of multi-disease-based approaches for diagnosis and treatment monitoring of several infectious diseases, including tuberculosis (TB), human immunodeficiency virus (HIV), viral hepatitis and sexually transmitted infections (STI). However, in many countries, diagnosis and monitoring, as well as disease response programs, still operate as vertical systems, potentially causing delay in diagnosis and burden to patients and preventing the optimal use of available resources. With countries facing both human and financial resource constraints, during the COVID-19 pandemic even more than before, it is important that available resources are used as efficiently as possible, potential synergies are leveraged to maximise benefit for patients, continued provision of essential health services is ensured. For the infectious diseases, TB, HIV, hepatitis C (HCV) and STI, sharing devices and integrated services starting with rapid, quality-assured, and complete diagnostic services is beneficial for the continued development of adequate, efficient and effective treatment strategies. Here we explore the current and future potential (as well as some concerns), importance, implications and necessary implementation steps for the use of platforms for multi-disease testing for TB, HIV, HCV, STI and potentially other infectious diseases, including emerging pathogens, using the example of the COVID-19 pandemic.
format Online
Article
Text
id pubmed-9306259
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher European Centre for Disease Prevention and Control (ECDC)
record_format MEDLINE/PubMed
spelling pubmed-93062592022-08-01 Integrated use of laboratory services for multiple infectious diseases in the WHO European Region during the COVID-19 pandemic and beyond Simões, Daniel Ehsani, Soudeh Stanojevic, Maja Shubladze, Natalia Kalmambetova, Gulmira Paredes, Roger Cirillo, Daniela Maria Avellon, Ana Felker, Irina Maurer, Florian P Yedilbayev, Askar Drobniewski, Francis Vojnov, Lara Johansen, Anne S Seguy, Nicole Dara, Masoud Euro Surveill Perspective Technical advances in diagnostic techniques have permitted the possibility of multi-disease-based approaches for diagnosis and treatment monitoring of several infectious diseases, including tuberculosis (TB), human immunodeficiency virus (HIV), viral hepatitis and sexually transmitted infections (STI). However, in many countries, diagnosis and monitoring, as well as disease response programs, still operate as vertical systems, potentially causing delay in diagnosis and burden to patients and preventing the optimal use of available resources. With countries facing both human and financial resource constraints, during the COVID-19 pandemic even more than before, it is important that available resources are used as efficiently as possible, potential synergies are leveraged to maximise benefit for patients, continued provision of essential health services is ensured. For the infectious diseases, TB, HIV, hepatitis C (HCV) and STI, sharing devices and integrated services starting with rapid, quality-assured, and complete diagnostic services is beneficial for the continued development of adequate, efficient and effective treatment strategies. Here we explore the current and future potential (as well as some concerns), importance, implications and necessary implementation steps for the use of platforms for multi-disease testing for TB, HIV, HCV, STI and potentially other infectious diseases, including emerging pathogens, using the example of the COVID-19 pandemic. European Centre for Disease Prevention and Control (ECDC) 2022-07-21 /pmc/articles/PMC9306259/ /pubmed/35866437 http://dx.doi.org/10.2807/1560-7917.ES.2022.27.29.2100930 Text en This article is copyright of the authors or their affiliated institutions, 2022. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution (CC BY 4.0) Licence. You may share and adapt the material, but must give appropriate credit to the source, provide a link to the licence, and indicate if changes were made.
spellingShingle Perspective
Simões, Daniel
Ehsani, Soudeh
Stanojevic, Maja
Shubladze, Natalia
Kalmambetova, Gulmira
Paredes, Roger
Cirillo, Daniela Maria
Avellon, Ana
Felker, Irina
Maurer, Florian P
Yedilbayev, Askar
Drobniewski, Francis
Vojnov, Lara
Johansen, Anne S
Seguy, Nicole
Dara, Masoud
Integrated use of laboratory services for multiple infectious diseases in the WHO European Region during the COVID-19 pandemic and beyond
title Integrated use of laboratory services for multiple infectious diseases in the WHO European Region during the COVID-19 pandemic and beyond
title_full Integrated use of laboratory services for multiple infectious diseases in the WHO European Region during the COVID-19 pandemic and beyond
title_fullStr Integrated use of laboratory services for multiple infectious diseases in the WHO European Region during the COVID-19 pandemic and beyond
title_full_unstemmed Integrated use of laboratory services for multiple infectious diseases in the WHO European Region during the COVID-19 pandemic and beyond
title_short Integrated use of laboratory services for multiple infectious diseases in the WHO European Region during the COVID-19 pandemic and beyond
title_sort integrated use of laboratory services for multiple infectious diseases in the who european region during the covid-19 pandemic and beyond
topic Perspective
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9306259/
https://www.ncbi.nlm.nih.gov/pubmed/35866437
http://dx.doi.org/10.2807/1560-7917.ES.2022.27.29.2100930
work_keys_str_mv AT simoesdaniel integrateduseoflaboratoryservicesformultipleinfectiousdiseasesinthewhoeuropeanregionduringthecovid19pandemicandbeyond
AT ehsanisoudeh integrateduseoflaboratoryservicesformultipleinfectiousdiseasesinthewhoeuropeanregionduringthecovid19pandemicandbeyond
AT stanojevicmaja integrateduseoflaboratoryservicesformultipleinfectiousdiseasesinthewhoeuropeanregionduringthecovid19pandemicandbeyond
AT shubladzenatalia integrateduseoflaboratoryservicesformultipleinfectiousdiseasesinthewhoeuropeanregionduringthecovid19pandemicandbeyond
AT kalmambetovagulmira integrateduseoflaboratoryservicesformultipleinfectiousdiseasesinthewhoeuropeanregionduringthecovid19pandemicandbeyond
AT paredesroger integrateduseoflaboratoryservicesformultipleinfectiousdiseasesinthewhoeuropeanregionduringthecovid19pandemicandbeyond
AT cirillodanielamaria integrateduseoflaboratoryservicesformultipleinfectiousdiseasesinthewhoeuropeanregionduringthecovid19pandemicandbeyond
AT avellonana integrateduseoflaboratoryservicesformultipleinfectiousdiseasesinthewhoeuropeanregionduringthecovid19pandemicandbeyond
AT felkeririna integrateduseoflaboratoryservicesformultipleinfectiousdiseasesinthewhoeuropeanregionduringthecovid19pandemicandbeyond
AT maurerflorianp integrateduseoflaboratoryservicesformultipleinfectiousdiseasesinthewhoeuropeanregionduringthecovid19pandemicandbeyond
AT yedilbayevaskar integrateduseoflaboratoryservicesformultipleinfectiousdiseasesinthewhoeuropeanregionduringthecovid19pandemicandbeyond
AT drobniewskifrancis integrateduseoflaboratoryservicesformultipleinfectiousdiseasesinthewhoeuropeanregionduringthecovid19pandemicandbeyond
AT vojnovlara integrateduseoflaboratoryservicesformultipleinfectiousdiseasesinthewhoeuropeanregionduringthecovid19pandemicandbeyond
AT johansenannes integrateduseoflaboratoryservicesformultipleinfectiousdiseasesinthewhoeuropeanregionduringthecovid19pandemicandbeyond
AT seguynicole integrateduseoflaboratoryservicesformultipleinfectiousdiseasesinthewhoeuropeanregionduringthecovid19pandemicandbeyond
AT daramasoud integrateduseoflaboratoryservicesformultipleinfectiousdiseasesinthewhoeuropeanregionduringthecovid19pandemicandbeyond
AT integrateduseoflaboratoryservicesformultipleinfectiousdiseasesinthewhoeuropeanregionduringthecovid19pandemicandbeyond